TrialEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology2011

A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial.

Sanjay J Mathew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.